Atezolizumab

Atezolizumab is a type of cancer treatment known as an immune checkpoint inhibitor. It works by helping the immune system recognize and attack cancer cells more effectively. Specifically, it targets a protein called PD-L1, which cancer cells use to evade detection by the immune system. By blocking this protein, atezolizumab enhances the body’s natural ability to fight cancer. It is used to treat various cancers, including lung and bladder cancer, and is administered through an intravenous infusion. This medication is part of a broader category of therapies aimed at harnessing the immune system to combat cancer.